Tag: NYU Langone Health

FDA Weighs New Application To Approve MDMA As First-Ever Psychedelic Medicine For PTSD + More About MAPS

Tina Marie (Ms. Cat)

A psychedelics-focused drug development company is officially asking the Food and Drug Administration (FDA) to review an application to approve MDMA as a prescription medication for the treatment of post-traumatic stress disorder (PTSD).

The MAPS Public Benefit Corporation (MAPS PBC) announced on Tuesday that it submitted the new drug application (NDA) to FDA, requesting an expedited review given that the agency previously designated the psychedelic as a breakthrough therapy.

FDA Weighs New Application To Approve MDMA As First-Ever Psychedelic Medicine For PTSD

H/T: The Most Revolutionary Act

The MAPS Public Benefit Corporation is subsidiary of Multidisciplinary Association for Psychedelic Studies. MAPS was founded by Rick Doblin.*

Related:

Read More »

‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?

Tina Marie (Ms. Cat)

A pair of new drugs offer something many Americans desperately want: a way to lose weight.

‘There’s no way that patients are going to be able to afford that.’ Why aren’t new drugs that can help you lose weight more widely used?

“Ten years ago, policymakers would come out and say, ‘Fat people need to eat less and move more.’” – majority of people still feel this way, unfortunately. Most of them don’t know how hard it is to lose weight or if they have, they don’t understand that one weight loss plan may not work for another. Same way it is with medical treatments. One size fits all doesn’t fit all!